GLP-1 medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) are powerful tools — but they work best as part of a real metabolic health plan. Dr. Lindsey Bailey, DO evaluates the full picture before prescribing.
A lot of clinics will hand you a GLP-1 prescription after a 5-minute intake form. That's not how we work. Weight that won't move is almost always a metabolic story — and we read the whole thing before we recommend anything.
Insulin resistance, thyroid function, inflammation markers, cortisol — the factors that determine whether weight loss is even possible without intervention.
Hormonal imbalances — especially thyroid and sex hormones — are among the most common hidden drivers of weight gain. We check them all.
If GLP-1 therapy is right for you, Dr. Bailey prescribes and monitors it carefully — adjusting dosing based on your response and tolerance.
Weight loss is a process, not an event. Dr. Bailey stays involved throughout — monitoring labs, adjusting protocols, and helping you build sustainable habits.
Yes. Dr. Bailey evaluates patients for GLP-1 and GIP/GLP-1 medications including tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) as part of a comprehensive weight loss and metabolic health program. Prescribing is based on a full medical evaluation — not a quick online form.
Both are injectable medications used for weight loss and blood sugar management, but they work differently. Ozempic (semaglutide) is a GLP-1 receptor agonist. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist — it activates two pathways instead of one, which is why clinical trials showed greater average weight loss with tirzepatide. Dr. Bailey evaluates which medication is most appropriate for your specific situation.
Yes. Dr. Bailey sees weight loss and metabolic health patients via telemedicine throughout Colorado, Arizona, and Nebraska. Lab work is ordered to a local draw site, and all consultations and follow-up are conducted via secure video or phone.
Medication is one tool — not the whole plan. The PeakLAB approach includes a comprehensive metabolic evaluation (hormones, thyroid, insulin resistance, inflammation markers), personalized nutrition and lifestyle guidance, and ongoing monitoring. The goal is sustainable metabolic health, not just a number on the scale.
GLP-1 medications are generally appropriate for adults with a BMI of 30 or higher, or 27+ with a weight-related condition such as type 2 diabetes, hypertension, or metabolic syndrome. Dr. Bailey evaluates each patient individually and considers the full clinical picture before recommending any medication.